26th Jun 2007 10:14
United Drug PLC26 June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (2) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (3) An issuer making a notification in respect of options grantedto a director/person discharging managerial responsibilities should completeboxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify MS. ANNETTE FLYNN the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 45,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 40,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 340, 000 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification ________ CLAIRE HEELEY ____________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (5) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (6) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (7) An issuer making a notification in respect of options grantedto a director/person discharging managerial responsibilities should completeboxes 1 to 3 and 17 to 24. (8) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of PERSONS DISCHARGING MANGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person MR. ALAN RALPH N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 45,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 45,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 398,497 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification __________ CLAIRE HEELEY _________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (9) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (10) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (11) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (12) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify MR. BARRY McGRANE the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 45,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 40,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 778,500 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification _________ CLAIRE HEELEY ___________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (13) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (14) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (15) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (16) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify MR. CHRIS CORBIN the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 45,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 40,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 651, 000 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification __________ CLAIRE HEELEY __________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (17) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (18) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (19) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (20) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of COMPANY SECRETARY 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify MS. CLAIRE HEELEY the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 20,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 5,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 145, 000 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification ___________ CLAIRE HEELEY _________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (21) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (22) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (23) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (24) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of PERSONS DISCHARGING MANGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person MR. LUKE BREHONY N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 40,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 40,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 381,000 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification __________ CLAIRE HEELEY __________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (25) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (26) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (27) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (28) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify MR. LIAM FITZGERALD the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 100,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 80,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 1,218, 000 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification ________ CLAIRE HEELEY ____________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (29) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (30) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (31) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (32) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of PERSONS DISCHARGING MANGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person MR. LIAM LOGUE N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 50,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 30,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 265,000 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification ___________ CLAIRE HEELEY _________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (33) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (34) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (35) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (36) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of PERSONS DISCHARGING MANGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person MR. MICK DUNNE N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 40,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 307,500 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification _________ CLAIRE HEELEY ___________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (37) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (38) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (39) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (40) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of PERSONS DISCHARGING MANGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person MR. SEAN QUIGLEY N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 40,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 40,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 165,000 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification _________ CLAIRE HEELEY ___________________________________________ Date of notification 25th June 2007 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (41) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (42) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (43) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (44) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i) 3 Name of PERSONS DISCHARGING MANGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person MR. VINCENT LONG N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Granting of stock options relating to Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Granting of stock options N/a 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares acquired N/a N/a 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class should financial instruments relating to not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 20th June 2007 N/a 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/a N/a If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 20th JUNE 2007 25,000 FROM 20 JUNE 2010 TO 19 JUNE 2017 5,000 FROM 20 JUNE 2012 TO 19 JUNE 2017 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) N/a Ordinary shares of €0.05 each 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 316,524 €0.05 ORDINARY SHARES €4.0623 Any additional information 24 Name of contact and telephone number for queries N/a CLAIRE HEELEY (01-4637721) Name and signature of duly designated officer of issuer responsible for making notification ________ CLAIRE HEELEY ____________________________________________ Date of notification 25th June 2007 This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
UDG.L